RecruitingNCT06087315

Evaluation of a Multi-country Medical Oxygen Program

Realist Evaluation and Learning in a Multi-country Medical OXYgen Program (REAL-MOXY)


Sponsor

Murdoch Childrens Research Institute

Enrollment

1,200 participants

Start Date

Nov 27, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

REAL-MOXY is a set of 5 mixed methods studies designed to understand how oxygen and pulse oximetry are used (or not used) at a facility level, to identify opportunities and barriers for strengthening oxygen systems for beneficiaries, users and managers.


Eligibility

Min Age: 0 YearsMax Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Multi-faceted oxygen systems strengthening interventions (different for each country) for people with hypoxemia, morality, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 0 Years to 15 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMulti-faceted oxygen systems strengthening interventions (different for each country)

The specific approaches are different in each country but broadly include efforts to: (1) strengthening policies, strategies, and governance of medical oxygen production, distribution, maintenance, and use; (2) building capacity of healthcare workers and technicians to use and maintain oxygen well, and (3) strengthening oxygen-related data acquisition and use for forecasting, budgeting, and monitoring.


Locations(3)

10 Facilities to Be Selected

Phnom Penh, Cambodia

10 Facilities to Be Selected

Ibadan, Nigeria

10 Facilities to Be Selected

Kampala, Uganda

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06087315


Related Trials